TNFα gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice

Journal of Nutritional Biochemistry

Volumn 23, Issue 12, 2012, Pages 1685-1693

  Salles, JérÔme ^a,b   Tardif, Nicolas ^a,b   Landrier, Jean François ^c,d   Mothe Satney, Isabelle ^e,f   Guillet, Christelle ^a,b   Boue Vaysse, Carole ^g   Combaret, Lydie ^a,b   Giraudet, Christophe ^a,b   Patrac, Véronique ^a,b   Bertrand Michel, Justine ^h   Denis, Philippe ^a,b   Chardigny, Jean Michel ^a,b   Boirie, Yves ^a,b   Walrand, Stéphane ^a,b  

^a CRNH AUVERGNE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSERM   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e INSERM   (France)

^f UNIVERSITÉ CÔTE D'AZUR   (France)

^g Institut des Corps Gras   (France)

^h IFR150   (France)

Author keywords

Fibrosis; High fat diet; Inflammation; Lipotoxicity; TNF KO mice

Indexed keywords

C REACTIVE PROTEIN; CERAMIDE; FATTY ACID; FATTY ACID TRANSPORTER; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GLUCOSE TOLERANCE TEST; HEART; INFLAMMATION; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIVER; LIVER FIBROSIS; LIVER WEIGHT; MALE; METABOLIC PARAMETERS; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WEIGHT GAIN; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; CERAMIDES; CYTOKINES; DIET, HIGH-FAT; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; ORGAN SIZE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84869089985     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.12.001     Document Type: Article

References (51)

1. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
2. Ford E.S., Williamson D.F., Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997, 146:214-222.
3. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Moscar J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
4. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
5. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 2006, 4:263-273.
6. Sethi J.K., Vidal-Puig A.J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 2007, 48:1253-1262.
7. Slawik M., Vidal-Puig A.J. Adipose tissue expandability and the metabolic syndrome. Genes Nutr 2007, 2:41-45.
8. Tan C.Y., Vidal-Puig A. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 2008, 36:935-940.
9. Unger R.H., Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. Faseb J 2001, 15:312-321.
10. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003, 14:281-287.
11. van Herpen N.A., Schrauwen-Hinderling V.B. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008, 94:231-241.
12. Virkamäki A., Korsheninnikova E., Seppälä-Lindroos A., Vehkavaara S., Goto T., Halavaara J., et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001, 50:2337-2343.
13. Krssak M., Falk Petersen K., Dresner A., DiPietro L., Vogel S.M., Rothman D.L., et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999, 42:113-116.
14. Perseghin G., Scifo P., De Cobelli F., Pagliato E., Mattezzati A., Arcelloni C., et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999, 48:1600-1606.
15. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999, 107:450-455.
16. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med 2005, 37:347-356.
17. Liu L., Zhang Y., Chen N., Shi X., Tsang B., Yu Y.H. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 2007, 117:1679-1689.
18. Bruce C.R., Thrush A.B., Mertz V.A., Bezaire V., Chabowski A., Heigenhause G.J., et al. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 2006, 291:E99-E107.
19. Choi C.S., Fillmore J.J., Kim J.K., Liu Z.X., Kim S., Collier E.F., et al. Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest 2007, 117:1995-2003.
20. Monetti M., Levin M.C., Watt M.J., Sajan M.P., Marmor S., Hubbard B.K., et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007, 6:69-78.
21. Yamaguchi K., Yang L., McCall S., Huang J., Yu X.X., Pandey S.K., et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007, 45:1366-1374.
22. Holland W.L., Knotts T.A., Chavez J.A., Wang L.P., Hoehn K.L., Summers S.A. Lipid mediators of insulin resistance. Nutr Rev 2007, 65:S39-S46.
23. Resjö S., Göransson O., Härndahl L., Zolnierowicz S., Manganiello V., Degerman E. Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal 2002, 14:231-238.
24. Stratford S., Hoehn K.L., Liu F., Summers S.A. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 2004, 279:36608-36615.
25. Powell D.J., Hajduch E., Kular G., Hundal H.S. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 2003, 23:7794-7808.
26. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
27. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
28. Uysal K.T., Wiesbrock S.M., Hotamisligil G.S. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 1998, 139:4832-4838.
29. Pamir N., McMillen T.S., Kaiyala K.J., Schwartz M.W., LeBoeuf R.C. Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 2009, 150:4124-4134.
30. Boura-Halfon S., Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 2009, 296:E581-E591.
31. Steinberg G.R., Michell B.J., van Denderen B.J., Watt M.J., Carey A.L., Farn B.C., et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 2006, 4:465-474.
32. De Taeye B.M., Novitskaya T., McGuinness O.P., Gleaves L., Medda M., Covington J.W., et al. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 2007, 293:E713-E725.
33. Bouter B., Geary N., Langhans W., Asarian L. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha. Metabolism 2010, 59:1065-1073.
34. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A 1997, 94:8093-8098.
35. Spencer M.J., Marino M.W., Winckler W.M. Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice. Neuromuscul Disord 2000, 10:612-619.
36. Chanséaume E., Tardy A.L., Salles J., Giraudet C., Rousset P., Tissandier A., et al. Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats. Obesity (Silver Spring) 2007, 15:50-59.
37. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
38. Laurent D., Yerby B., Deacon R., Gao J. Diet-induced modulation of mitochondrial activity in rat muscle. Am J Physiol Endocrinol Metab 2007, 293:E1169-E1177.
39. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
40. Barrans A., Collet X., Barbaras R., Jaspard B., Manent J., Vieu C., et al. Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 1994, 269:11572-11577.
41. Vieu C., Tercé F., Chevy F., Rolland C., Barbaras R., Chap H., et al. Coupled assay of sphingomyelin and ceramide molecular species by gas liquid chromatography. J Lipid Res 2002, 43:510-522.
42. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
43. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996, 184:1397-1411.
44. Nishikawa S., Yasoshima A., Doi K., et al. Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL/6J and BALB/cA mice. Exp Anim 2007, 56:263-272.
45. Cawthorn W.P., Sethi J.K. TNF-alpha and adipocyte biology. FEBS Lett 2008, 582:117-131.
46. Marini M.A., Succurro E., Frontoni S., et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007, 30:2145-2147.
47. Stefan N., Kantartzis K., Machann J., et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168:1609-1616.
48. Hotamisligil G.S., Johnson R.S., Distel R.J., et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996, 274:1377-1379.
49. Kim J.Y., van de Wall E., Laplante M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007, 117:2621-2637.
50. Koonen D.P., Jacobs R.L., Febbraio M., et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56:2863-2871.
51. Ruan H., Miles P.D., Ladd C.M., et al. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 2002, 51:3176-3188.